Literature DB >> 9546326

Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels.

J Bufler1, R Pitz, M Czep, M Wick, C Franke.   

Abstract

The mechanism of block of nicotinic acetylcholine receptor (nAChR) channels by purified antibodies from patients with myasthenia gravis (MG) was investigated by using an ultrafast system for solution exchange at outside-out patches. IgG of MG patients and controls was purified by using protein A-Sepharose columns. Probes from 9 seropositive MG patients and 3 seronegative MG patients were tested. As a preparation, cultured mouse myotubes expressing the embryonic-type nAChR channels were used. Twenty-millisecond pulses of 1.0 mM ACh were applied repetitively to outside-out patches. Outside-out patches were preexposed with IgG in concentrations between 0.1 and 200 mg/L during application of ACh pulses. The peak current amplitude was reduced to values between 6% and 71% of control for the 9 seropositive and 3 seronegative MG patients. The block was concentration dependent and fully reversible after washout of antibodies. Incubation with IgG from different control patients did not reduce the peak current amplitude. In addition, our findings with purified IgG from seronegative MG patients support the idea of the immunopathogenesis of this disorder and may allow the development of a diagnostic test for seronegative MG patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546326     DOI: 10.1002/ana.410430408

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

1.  Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions.

Authors:  Rumi Sato; Shiho Imamoto; Iku Utsnomiya; Terumasa Chiba; Kyoji Taguchi; Kenji Abe; Keiko Tanaka; Tadashi Miyatake
Journal:  Neurol Sci       Date:  2013-02-07       Impact factor: 3.307

2.  Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current.

Authors:  Z Wang; P A Low; J Jordan; R Freeman; C H Gibbons; C Schroeder; P Sandroni; S Vernino
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

3.  ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].

Authors:  B Hain; F Hanisch; M Deschauer
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

4.  Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.

Authors:  Hakan Cetin; Richard Webster; Wei Wei Liu; Akiko Nagaishi; Inga Koneczny; Fritz Zimprich; Susan Maxwell; Judith Cossins; David Beeson; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-12       Impact factor: 10.154

Review 5.  Autoimmune synaptopathies.

Authors:  Sarah J Crisp; Dimitri M Kullmann; Angela Vincent
Journal:  Nat Rev Neurosci       Date:  2016-02       Impact factor: 34.870

6.  IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.

Authors:  Maria Isabel Leite; Saiju Jacob; Stuart Viegas; Judy Cossins; Linda Clover; B Paul Morgan; David Beeson; Nick Willcox; Angela Vincent
Journal:  Brain       Date:  2008-05-31       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.